Rallybio Corporation (RLYB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 30.91M |
| Enterprise Value | -292,759 |
| P/E Ratio | 3.43 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 196.01 |
| Price/Book Ratio | 0.98 |
| Enterprise/Revenue | -12.97 |
| Enterprise/EBITDA | -0.18 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 61.77 |
| Operating Margin | -46.59 |
| Return On Assets | 0.28 |
| Return On Equity | 0.36 |
| Revenue | 858,000 |
| Revenue/Share | 0.08 |
| Gross Profit | 766,000 |
| EBITDA | -27.97M |
| Net Income | -8.98M |
| Diluted EPS | -1.59 |
| Total Cash | 90.69M |
| Total Cash/Share | 15.87 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 28.87 |
| Book Value Per Share | 16.15 |
| 52-Week Change | 180.14 |
| 52-Week High | 17.57 |
| 52-Week Low | 3.67 |
| Moving Average 50 Days | 16.59 |
| Moving Average 200 Days | 13.3 |
| Average Volume | 18,317 |
| Shares Outstanding | 5.38M |
| % Held by Institutions | 71.35 |
| Trailing Annual Dividend Rate | 13.56 |
| Trailing Annual Dividend Yield | 85.82 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | February 06, 2026 |